Furosemide inhibits regenerative cortical spreading depression in anaesthetized cats

Cephalalgia

Volumn 17, Issue 8, 1997, Pages 826-832

  Read, S J ^a,b   Smith, M I ^a   Benham, C D ^a   Hunter, A J ^a   Parsons, A A ^a  

^a SmithKliiie Bcccliam Phatmaceulicals   (United Kingdom)

^b New Fmutiers Science Park   (United Kingdom)

Author keywords

Cortical spreading depression; Furosemide; Migraine

Indexed keywords

FUROSEMIDE; LOOP DIURETIC AGENT;

ACID BASE BALANCE; ANIMAL EXPERIMENT; ARTICLE; CAT; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; HEADACHE; INTRAVENOUS DRUG ADMINISTRATION; MIGRAINE; NONHUMAN; PATHOPHYSIOLOGY; SPREADING CORTICAL DEPRESSION;

ANALYSIS OF VARIANCE; ANESTHETICS; ANIMALS; CATS; CEREBROVASCULAR CIRCULATION; FUROSEMIDE; NERVE REGENERATION; SPREADING CORTICAL DEPRESSION;

EID: 0031467679     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1997.1708826.x     Document Type: Article

References (16)

1. Kempski O, von Rosen S, Weigt H, Staub F, Peters J, Baethman A. Glial ion transport and volume control. Ann NY Acad Sei 1991;633:306-17
2. Baethmann A, Maier-Hauff K, Kempski O, Unterberg A, Wahl M, Schurer L. Mediators of brain oedema and secondary brain damage. Crit Care Med 1996;16:972-8
3. Chebabo SR, Hester MA, Aitken PG, Somjen GG. Hypotonie exposure enhances synaptic transmission and triggers spreading depression in rat hippocampal tissue slices. Brain Res 1995;695:203-16
4. Kimelberg HK, Ransom BR. Cell biology and pathology of astrocytes. In: Fedoeroff S, Vernadakis A, editors. Astrocytes. New York: Academic Press, 1986
5. Walz W, Hertz L. Intense furosemide-sensitive potassium accumulation in astrocytes in the presence of pathologically high extracellular potassium levels. J Cereb Blood Flow Metab 1984;4:301-4
6. Goadsby PJ, Kaube H, Hoskin KL. Nitric oxide couples cerebral blood flow and metabolism. Brain Res 1992;595: 167-70
7. Read SJ, Smith MI, Hunter AJ, Parsons AA. Measurement of nitric oxide release using a selective microelectrode following repeated waves of cortical spreading depression. Br J Pharmacol 1996;118:79P
8. Wahl M, Schilling L, Parsons AA, Kaumann A. Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilatation elicited by cortical spreading depression. Brain Res 1994;637:204-10
9. Read SJ, Smith MI, Hunter AJ, Parsons AA. Enhanced NO release during cortical spreading depression following infusion of glyceryl trinitrate in the anaesthetised cat. Cephalalgia 1997;17:159-65
10. Read SJ, Smith MI, Hunter AJ, Parsons AA. The dynamics of nitric oxide release measured in real time following repeated waves of cortical spreading depression in the anaesthetised cat. Neurosci Lett 1997;232:127-30
11. Hochman DW, Baraban SC, Owens JWM, Schwartzkroin PA. Dissociation of synchronisation and excitability in furosemide blockade of epileptiform activity. Science 1995;270:99-102
12. Baran H, Lassmann H, Sperk G, Seitelberger F, Homykiewicz O. Effect of mannitol treatment on brain neurotransmitter markers in kainic acid-induced epilepsy. Neuroscience 1987;21:679-84
13. Johansen CE, Murphy VA, Dyas M. Ethacrynic acid and furosemide alter Cl, K, and Na distribution between blood, choroid plexus, CSF, and brain. Neurochem Res 1992;17: 1079-85
14. Korpi ER, Kuner T, Seeburg PH, Luddens H. Selective antagonist for the cerebellar granule specific gamma aminobutyric acid type A receptor. Mol Pharmacol 1995;47:283-9
15. Roseth S, Fykse EM, Fonnum F. Uptake of L-glutamate into rat brain synaptic vesicles: effect of inhibitors that bind specifically to the glutamate transporter. J Neurochem 1995; 65:96-103
16. Lauritzen M. Cortical spreading depression as a putative migraine mechanism. TINS 1987;10:8-13